CUSI, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 11.064
EU - Europa 9.489
AS - Asia 1.376
SA - Sud America 23
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 17
Totale 22.007
Nazione #
US - Stati Uniti d'America 11.022
GB - Regno Unito 2.575
IE - Irlanda 2.042
IT - Italia 1.329
CN - Cina 1.108
UA - Ucraina 970
SE - Svezia 967
FR - Francia 558
DE - Germania 518
FI - Finlandia 311
VN - Vietnam 76
ES - Italia 67
TR - Turchia 59
IN - India 43
BE - Belgio 42
CA - Canada 35
EU - Europa 19
HK - Hong Kong 19
RU - Federazione Russa 17
AT - Austria 13
AU - Australia 11
NL - Olanda 11
JP - Giappone 10
PL - Polonia 10
IM - Isola di Man 9
IR - Iran 9
BR - Brasile 8
IQ - Iraq 8
RS - Serbia 8
CL - Cile 7
KR - Corea 7
SA - Arabia Saudita 7
GR - Grecia 6
NZ - Nuova Zelanda 6
MT - Malta 5
PH - Filippine 5
PK - Pakistan 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
GH - Ghana 4
MW - Malawi 4
PE - Perù 4
SC - Seychelles 4
SG - Singapore 4
BD - Bangladesh 3
PA - Panama 3
PT - Portogallo 3
TH - Thailandia 3
ZA - Sudafrica 3
BG - Bulgaria 2
BZ - Belize 2
CY - Cipro 2
EE - Estonia 2
HU - Ungheria 2
ID - Indonesia 2
LU - Lussemburgo 2
MA - Marocco 2
MK - Macedonia 2
MX - Messico 2
NG - Nigeria 2
VE - Venezuela 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
CO - Colombia 1
DK - Danimarca 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
LT - Lituania 1
LV - Lettonia 1
ME - Montenegro 1
MY - Malesia 1
NO - Norvegia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 22.007
Città #
Southend 2.334
Dublin 2.006
Fairfield 1.564
Chandler 1.156
Ashburn 890
Woodbridge 799
Jacksonville 782
Wilmington 649
Seattle 647
Houston 572
Cambridge 556
Ann Arbor 501
Siena 440
Princeton 346
Nanjing 271
Menlo Park 244
Beijing 243
Helsinki 146
New York 144
Boardman 122
San Mateo 116
Nanchang 100
San Diego 92
Fremont 76
Dong Ket 67
Málaga 58
Dearborn 57
Shanghai 55
Shenyang 53
Hebei 51
Rome 50
Izmir 45
Florence 44
Tianjin 43
London 41
Norwalk 41
Brussels 39
Kunming 33
Lancaster 33
Jiaxing 31
Venezia 31
Changsha 29
San Francisco 28
Milan 25
Toronto 24
Jinan 23
Los Angeles 23
Washington 23
Redwood City 19
Lappeenranta 17
Auburn Hills 16
Ningbo 16
Guangzhou 15
Padova 15
Düsseldorf 14
Hangzhou 14
Iesi 14
Zhengzhou 14
Vienna 13
Hong Kong 12
Taizhou 12
Hounslow 11
Lanzhou 11
Frankfurt am Main 10
Cagliari 9
Falls Church 9
Haikou 9
Hefei 9
Kilburn 9
Palermo 9
Belgrade 8
Douglas 8
Edinburgh 8
Fuzhou 8
Mestre 8
Philadelphia 8
Hanoi 7
Madrid 7
Messina 7
Trieste 7
Bari 6
Changchun 6
Falkenstein 6
Hanover 6
Montreal 6
Phoenix 6
Saint Petersburg 6
San Jose 6
Sydney 6
Tokyo 6
Athens 5
Bangalore 5
Groningen 5
Leawood 5
Mumbai 5
New Bedfont 5
Pescara 5
Poli 5
Prato 5
Prescot 5
Totale 16.206
Nome #
ERITEMA NODOSO RECIDIVANTE E PERSISTENTE REPLICA DI EPSTEIN-BARR VIRUS 269
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 239
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 230
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients 224
A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease 222
Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccine. 214
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 196
Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection. 192
ANDAMENTO LONGITUDINALE DI BIOMARKERS DI INFIAMMAZIONE ED IMMUNOATTIVAZIONE IN PAZIENTI SOTTOPOSTI A TRAPIANTO DI RENE: UN RUOLO DELLA REPLICAZIONE DI CMV? 189
Non-granulomatous cerebellar infection by Acanthamoeba spp. in an immunocompetent host 189
Valutazione di un test in chemiluminescenza per la diagnosi sierologica di Leishmaniosi Viscerale 179
Peripheral biomarkers' panel for severe COVID-19 patients 176
Peptidi epitopici immunogenici del CEA da utilizzare nella chemio-immunoterapia del carcinoma del colon-retto e della mammella. 175
Immunization with Toscana virus N-Gc proteins protects mice against virus challenge 175
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 171
Serological evidence of reinfection among vaccinees during rubella outbreak. 167
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 164
In vitro neuraminidase inhibitory effect and activity against influenza virus A H1N1 of herbal drugs used for common cold 164
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 164
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 162
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 162
Seroprevalence of hepatitis E virus (HEV) infection in blood donors and renal transplant recipients: a retrospective study from central Italy [Sieroprevalenza dell’infezione da virus dell’epatite E (HEV) in donatori di sangue e pazienti trapiantati di rene: Uno studio retrospettivo dal centro Italia] 156
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis 155
Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis 150
Testicular involvement during Toscana-virus infection: an unusual manifestation? 148
HCMV infection in renal transplant recipients: a retrospective cohort study 148
EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma. 147
Un rarissimo caso di infestazione parassitaria cerebellare da Acanthamoeba spp. In soggetto immunocompetente: primo caso in Italia. 145
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 144
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 142
Fast duplex one-step RT-PCR for rapid differential diagnosis of entero- or toscana virus meningitis 140
FIBRILLO-FLUTTER IN ASSENZA DI SEGNI DI MIOCARDITE IN CORSO DI INFEZIONE DA EBV 138
Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience 138
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 137
Toscana virus induces interferon although its NSs protein reveals antagonistic activity. 136
Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients. 135
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120 135
Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs. 134
Retrospective diagnosis of West Nile virus infection in a patient with meningoencephalitis in Tuscany, Italy 134
Antipeptide monoclonal antibodies inhibit the binding of rabies virus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 134
Cetuximab +/- chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro 133
Immune response analysis to Measles virus in subjects vaccinated with MMR vaccine and naturally infected subjects. 133
Virosoma dell'influenza immunoricostituito (IRIV) contenente il gene per CD40L come immunoprotettore tumorale CEA-specifico e usi immunogenici di esso. 132
Comparison of a new prototype immunochromatographic assay and a commercial enzyme-linked immunosorbent assay for the detection of serum antibodies against Toscana virus. 129
Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020 129
Tumour associated antigen (TAA) specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes 128
Beyond the biological effect of a chemically characterized poplar propolis: Antibacterial and antiviral activity and comparison with flurbiprofen in cytokines release by LPS-stimulated human mononuclear cells 128
Efficient delivery of DNA to dendritic cells mediated by influenza virosomes 127
Biotechnology for virus vaccine design, production, and control 126
Antibody response to wild rubella virus structural proteins following immunization with RA 27/3 live attenuated vaccine 125
Evaluation of a novel immunogenic vaccine platform based on a genome replication-deficient Sendai vector. 124
Effetti della dieta sulla secrezione di calcitonina nel neonato [The effects of diet on the secretion of calcitonin in the newborn infant] 123
5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine 122
Synthetic peptides of rubella E1 glycoprotein for serological assays 121
Seroprevalence of antibodies to Sandfly fever Sicilian virus in a sample population in Tuscany, Italy 121
Toscana Virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. 121
Age-dependent seroprevalence of Toscana virus in central Italy and correlation with the clinical profile 121
Diagnostic tools for Toscana virus infection. 120
Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects 118
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial) 118
Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients. 116
Rapid identification of Toscana virus by nested PCR during an outbreak in the Siena area of Italy 115
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 115
Immunological characterization of Respiratory Syncytial Virus N protein epitopes recognized by human cytotoxic T lymphocytes 114
Histological description of the lymphadenopathy related to Toscana virus infection. Report of a case. 113
Nucleotide variability of Toscana virus M segment in strains isolated from clinical cases 113
Comparative study of the immune response in mice immunized with four live attenuated strains of mumps virus by intranasal or intramuscular route. 113
null 113
Applications of Influenza Virosomes as a delivery system 112
Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them. 112
Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine 112
null 112
SARS-CoV-2 in pleural fluid in a kidney transplant patient 112
Epidemiological and clinical study of viral respiratory tract infections in children from Italy 111
Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein 111
Pathogenic mechanism of Helicobacter pylori: production of cytoxin 111
Serum antibody response to respiratory syncytial virus F and N proteins in two populations at high risk of infection: children and elderly 111
Analisi retrospettiva su infezioni invasive e non invasive da batteri Gram negativi non fermentanti in pazienti ospedalizzati 110
Compartimentalizzazione di HCMV: mancata appropiatezza della sola DNAemia nella diagnosi e nella terapia di una polmonite da HCMV post-trapianto polmonare 109
Specific antibody patterns over a two-year period after rubella immunization with RA 27/3 live attenuated vaccine 109
Pathogenic mechanisms of Helicobacter pylori: production of cytotoxin. 109
Encephalitis without meningitis due to sandfly fever virus serotype toscana 109
Rapid detection of different RNA respiratory virus species by multiplex RT-PCR: application to clinical specimens 109
RSV and HMPV seroprevalence in Tuscany (Italy) and North-Rhine Westfalia (Germany) in the winter season 2009/2010 108
Neutralization of Toscana virus is partially mediated by antibodies to the nucleocapsid protein 108
Bayesian skyline plot inference of the Toscana virus epidemic: a decline in the effective number of infections over the last 30 years 107
Potential of DNA vaccines delivered by influenza virosomes 106
In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouse 106
Editorial overview: Anti-infectives: Towards novel antiviral and antibacterial drugs? Current approaches to address a growing medical need 106
null 106
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients 106
Toscana Virus Nucleoprotein” () 105
Recombinant Nucleoprotein of Toscana virus. 105
In vitro generation of cytotoxic T lymphocytes against HLA-A2.1-restricted peptides derived from human thymidylate synthase 105
Serological and molecular detection of Toscana and other Phleboviruses in patients and sandflies in Tunisia. 105
Antibody response to SARS-CoV-2 in infected patients with different clinical outcome 104
Models of active specific immuno-therapy of human malignancy bone metastases. 103
Editorial: arthropod-borne viruses and emergent viruses. 103
null 103
A Mediterranean arbovirus: the Toscana virus 103
Totale 13.578
Categoria #
all - tutte 68.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.850


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.144 0 0 0 0 0 0 0 0 0 0 611 533
2019/20204.259 537 142 297 676 271 305 376 568 345 368 101 273
2020/20213.786 158 407 108 343 236 540 191 506 438 289 279 291
2021/20222.638 166 275 145 214 128 89 127 142 221 283 252 596
2022/20234.197 261 339 530 560 418 845 84 357 436 105 172 90
2023/20242.897 111 108 268 188 106 840 1.093 75 18 77 13 0
Totale 22.373